Previous 10 | Next 10 |
2023-12-27 02:55:50 ET Summary Novavax faces major challenges in 2024, including a significant Gavi dispute and going concern issues. Recent financial results show declining revenues and cash reserves, with a high operational cash burn rate. Market sentiment is cautious, with ...
2023-12-26 07:02:44 ET More on BioNTech, Moderna, etc. BioNTech's COVID-19 Success Paves The Way For A Strong Drug Pipeline Pfizer: Buy The Panic Pfizer Is Not Cheap, And The 5.7% Yield Is Not As Safe As You Might Think Citi puts Pfizer on catalyst watch afte...
2023-12-25 10:03:02 ET Summary I discuss my investment and trading strategies before and after March 2022. I highlight the importance of trade income, capital gains, dividend collection, and tax harvesting in my investment approach. I want to see the Bull Plateau (or Bear-Mark...
2023-12-20 13:46:26 ET Summary Pfizer's stock reached an all-time high in 2021 due to high demand for its COVID-19 vaccine but has since declined by 45% year-to-date. The company has revised its financial guidance for FY24, expecting significantly lower sales and profits. Decl...
Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization in Taiwan PR Newswire Novavax's updated vaccine will be available at vaccination centers across Taiwan GAITHERSBURG, Md. , Dec. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq:...
2023-12-18 05:43:43 ET Summary The best performance of the bull plateau is to advance steadily, not to move monotonously, and support for loyal cash cows. The article discusses winners in various categories such as Mega-Cap Group, Large-Cap Group, Small-Cap Group, Top Gains, All T...
2023-12-13 11:18:26 ET More on Pfizer Johnson & Johnson Vs. Pfizer: Better Pharma Stock? Pfizer: This Year's Disaster Should Set The Stage For A Strong 2024 Pfizer: Slimming Down After COVID Franchise And Obesity Pipeline Setbacks Biggest stock movers tod...
Canadians Can Help Protect Loved Ones as We Head into the Holiday Season Canada NewsWire Novavax launches Choose to Protect™ campaign to educate public about importance of updated COVID-19 vaccination Recent survey finds that 70% of Canadians believe in the va...
2023-12-05 16:56:15 ET More on Novavax Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference (Transcript) Novavax: Less Is Less - Shrinking COVID Market Takes Its Toll (Rating Downgrade) Novavax: The COVID Gig Is Over Novavax settles class a...
Novavax's Updated COVID-19 Vaccine Now Authorized in Canada Canada NewsWire Novavax's updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming days GAITHERSBURG, Md. , Dec. 5, 2023 ...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine PR Newswire Novavax's JN.1 COVID-19 vaccine is active against current circulating strains, including KP.2 and KP.3 GAITHERSBURG, Md. , Ju...
Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine PR Newswire Novavax's updated JN.1 COVID-19 vaccine is active against current circulating strains, including KP.2 and KP.3 Novavax's JN.1 COVID-19 vaccine w...